Observed and expected mortality in the german skin cancer screening pilot project screen

Nora Eisemann*, Annika Waldmann, Bernd Holleczek, Alexander Katalinic

*Corresponding author for this work


Objective: The ma purpose of skin cancer screening is melanoma mortality reduction. Before the implementation of nationwide German skin cancer screening, the pilot project SCREEN was conducted in Schleswig-Holstein in 2003–2004. We aimed to determine whether the pilot project had achieved a mortality reduction. Methods: Using an incidence-based approach (patients with both melanoma diagnosis and death in 2003–2008), we compared the observed melanoma mortality of the SCREEN cohort to the melanoma mortality expected without screening in the general population of Saarland. Results: The age- and sex-standardized melanoma mortality ratio (SMR) for 5.5 years of follow-up was 0.59 (95% confidence interval, 0.40–0.83). Conclusion: Our results indicate reduced mortality in the SCREEN cohort. Several potential biases cannot be excluded, but most of them tend to inflate the SMR.

Original languageEnglish
JournalJournal of Medical Screening
Issue number3
Pages (from-to)166-168
Number of pages3
Publication statusPublished - 01.01.2018

Research Areas and Centers

  • Research Area: Center for Population Medicine and Public Health (ZBV)


Dive into the research topics of 'Observed and expected mortality in the german skin cancer screening pilot project screen'. Together they form a unique fingerprint.

Cite this